Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab for Severe Chronic Rhinosinusitis with Nasal Polyps
NCT03450083Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2017
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of benralizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Johns Hopkins University. Started Jul 2017; status: completed.
02
Drugs
benralizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT03450083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450083.